Skip to content

Correlation Between Serum Parathyroid Hormone and Alkaline Phosphatase in Chronic Kidney Disease Patients: A Study from Central India

Correlation Of Serum Intact Parathyroid Hormone and Serum Alkaline Phosphatase Amongst the Patients of Chronic Kidney Disease in A Rural Tertiary Care Hospital in Central India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069287
Enrollment
120
Registered
2024-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

None listed

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: This is a single-center observational prospective study conducted at the AVBRH hospital under the Department of Nephrology. All patients on regular follow-up and on maintenance haemodialysis treatment from Acharya Vinoba Bhave Rural Hospital were eligible for participation, subject to the inclusion and exclusion criteria.

Exclusion criteria

Exclusion criteria: Age more than 18 years diagnosed to have Chronic kidney disease Stage IV, V and patient on Dialysis

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is to determine the correlation between serum intact parathyroid hormone (iPTH) and serum alkaline phosphatase (ALP) levels among patients with Chronic Kidney Disease (CKD) in a rural tertiary care hospital in Central IndiaTimepoint: All parameters will be assessed at the baseline at the time of enrollment.

Secondary

MeasureTime frame
In addition to the primary outcome of correlating serum intact parathyroid hormone (iPTH) and serum alkaline phosphatase (ALP) levels in Chronic Kidney Disease (CKD) patients, this study aims to determine the prevalence of mineral and bone disorder (MBD) in CKD patients, analyze disease burden across CKD stages, explore factors influencing iPTH and ALP levels, evaluate their relationship with other biochemical markers and clinical parameters, identify predictors of adverse outcomes, assess intervention impacts on iPTH and ALP levels, and compare iPTH and ALP levels between dialysis and non-dialysis CKD patients. Timepoint: 1 Month

Countries

India

Contacts

Public ContactManish Balwani

Datta Meghe Institute of Higher Education and Research

Sunnymalde94@gmail.com8983366987

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026